What is CVE-2024-35429?

CVE-2024-35429 is a medium-severity vulnerability in Zkteco Zkbio Cvsecurity, classified under Path Traversal. CVSS score: 6.5/10. Published 2024-05-30.

How severe is CVE-2024-35429?

Medium severity. CVSS v3 base score is 6.5 out of 10.

Is CVE-2024-35429 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

Path Traversal in Zkteco Zkbio Cvsecurity

CVE-2024-35429

ZKTeco ZKBio CVSecurity 6.1.1 is vulnerable to Directory Traversal via eventRecord.

Vulnerability class: Path Traversal (Directory Traversal)

Published 2024-05-30 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N.

EPSS exploit prediction

EPSS: 0.009 (59.6th percentile), scored 2026-09-30.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 60th percentile — 59.6% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.009 · newest: 0.009 · change: 0.000

Affected products

Zkteco Zkbio Cvsecurity — versions 6.1.1

Weakness classification (CWE)

Public proof-of-concept exploits

fkie-cad/nvd-json-data-feeds

References

github.com/mrojz/ZKT-Bio-CVSecurity/blob/main/CVE-2024-35429.md (Exploit, Third Party Advisory)

Frequently asked questions

What is CVE-2024-35429?: CVE-2024-35429 is a medium-severity vulnerability in Zkteco Zkbio Cvsecurity, classified under Path Traversal. CVSS score: 6.5/10. Published 2024-05-30.
How severe is CVE-2024-35429?: Medium severity. CVSS v3 base score is 6.5 out of 10.
Is CVE-2024-35429 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.